AIN Holdings Inc
TSE:9627
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 303
6 281
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
AIN Holdings Inc
Total Equity
AIN Holdings Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
AIN Holdings Inc
TSE:9627
|
Total Equity
ÂĄ134.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
12%
|
||
Sundrug Co Ltd
TSE:9989
|
Total Equity
ÂĄ253.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
||
Tsuruha Holdings Inc
TSE:3391
|
Total Equity
ÂĄ286.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
||
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Total Equity
ÂĄ243.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Total Equity
ÂĄ517.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
20%
|
CAGR 10-Years
13%
|
||
Cosmos Pharmaceutical Corp
TSE:3349
|
Total Equity
ÂĄ237.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
AIN Holdings Inc
Glance View
Ain Holdings, Inc. engages in the operation of dispensing pharmacies and drug stores. The company is headquartered in Sapporo, Hokkaido and currently employs 9,019 full-time employees. The firm has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
See Also
What is AIN Holdings Inc's Total Equity?
Total Equity
134.3B
JPY
Based on the financial report for Jul 31, 2024, AIN Holdings Inc's Total Equity amounts to 134.3B JPY.
What is AIN Holdings Inc's Total Equity growth rate?
Total Equity CAGR 10Y
12%
Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for AIN Holdings Inc have been 6% over the past three years , 5% over the past five years , and 12% over the past ten years .